Literature DB >> 3166073

The occurrence of acute lymphoblastic leukemia shortly after the cessation of human growth hormone therapy.

M Ogawa1, O Mori, T Kamijo, H Tomita, T Yazawa, K Miwa, K Tsukidate, M Ogura, R Ohno.   

Abstract

We encountered a case of a 21-year-old man who had developed acute lymphoblastic leukemia (ALL) shortly after the cessation of approximately six years' human growth hormone treatment for pituitary dwarfism. The patient had also been treated with thyroid preparations and methylandrostanolone, a kind of anabolic steroid. Factors relating to the onset of ALL in this case are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166073

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Malignant thymoma in a patient with growth hormone deficiency during growth hormone therapy.

Authors:  T Hasegawa; Y Hasegawa; S Koto; T Aso; Y Tsuchiya; A Hayashi; H Ishida; Y Morikawa
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

2.  Fr-MLV infection induces erythroleukaemia instead of lymphoid leukaemia in mice given pituitary grafts.

Authors:  G Fontanini; F Basolo; C Garzelli; F Squartini; A Toniolo
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

3.  Risk factors for leukemia occurrence among growth hormone users.

Authors:  S Watanabe; N Yamaguchi; Y Tsunematsu; A Komiyama
Journal:  Jpn J Cancer Res       Date:  1989-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.